Case report: Chronic hepatitis C with anti-HCV positive and serum HCV RNA negative

Case report: Chronic hepatitis C with anti-HCV positive and serum HCV RNA negative

Bibliographic Details
Main Authors:	Huihui Lu, Wen Deng, Yao Lu, Lu Zhang, Yao Xie, Minghui Li
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-04-01
Series:	Gastroenterology & Endoscopy
Subjects:	Hepatitis Occult hepatitis C viral Infection Antiviral therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S294975232200005X

Similar Items

HCV-Specific T Cell Responses During and After Chronic HCV Infection
by: Hendrik Luxenburger, et al.
Published: (2018-11-01)

Evaluation of impact of occult hepatitis B infection in chronic HCV-infected patients: A retrospective cohort study
by: Mohit Bhatia, et al.
Published: (2018-07-01)

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin
by: Guillermo Cabrera Álvarez, et al.
Published: (2011-10-01)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
by: Pierre Nahon, et al.
Published: (2021-01-01)

Association of Hepatitis C Virus (HCV) Infection and Human Leukocyte Antigens (HLA)
by: Abdul-Razak SH Hasan, et al.
Published: (2019-11-01)

Association of Hepatitis C Virus (HCV) Infection and Human Leukocyte Antigens (HLA)
by: Abdul-Razak SH Hasan, et al.
Published: (2019-11-01)

Occult Hepatitis B Demonstrated by Anti-HBc and HBV DNA in HIV-Positive Patients
by: Arezoo Honarmand, et al.
Published: (2014-10-01)

Quantitation of HCV RNA in liver of patients with chronic hepatitis C Quantificação do RNA-HCV no fígado de pacientes com hepatite C crônica
by: Ana de Lôurdes Candolo MARTINELLI, et al.
Published: (2000-10-01)

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
by: Nancy Abdel Fattah Ahmed, et al.
Published: (2020-08-01)

Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection
by: Habibollahi Peiman, et al.
Published: (2009-01-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
by: S N Batskikh, et al.
Published: (2018-11-01)

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
by: A. M. Falla, et al.
Published: (2018-01-01)

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
by: Tuğrul Himmetoğlu, et al.
Published: (2007-07-01)

New antiviral agents and new treatments on the horizon for the management of viral hepatitis
by: M. Sönmezoğlu
Published: (2011-12-01)

Evaluation of HCV-related liver fibrosis post-successful DAA therapy
by: Nermine Ehsan, et al.
Published: (2021-06-01)

Hepatitis C III. Estudio laparoscópico, histológico y niveles séricos de alanina aminotransferasa en 160 pacientes seropositivos al virus de la hepatitis C Hepatitis C III. Laparoscopic and histological study and serum levels of alanine aminotransferase in 160 HCV seropositive patients
by: Jorge Valdés Moreno, et al.
Published: (2005-03-01)

Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure
by: João Paulo Vilela Rodrigues, et al.
Published: (2022-11-01)

Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
by: Hsin-Yun Sun, et al.
Published: (2022-06-01)

Management of HCV Infection and Liver Transplantation
Published: (2006-04-01)

HCV RNA in peripheral blood mononuclear cells (PBMCs) as a predictor of the response to antiviral therapy in chronic hepatitis C
by: Abdel Fatah Fahmy Hanno, et al.
Published: (2014-12-01)

HBV COVALENTLY CLOSED CIRCULAR DNA AS A MARKER OF PREVALENCE OF OCCULT HEPATITIS В IN PATIENTS WITH HBV, HDV AND HCV INFECTION IN UZBEKISTAN
by: A. V. Semenov, et al.
Published: (2016-10-01)

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up
by: Hsing-Yu Chen, et al.
Published: (2017-09-01)

Chronic hepatitis C elimination prison initiative: HCV‐intensive test and treat, a whole prisoner population HCV test‐and‐treat program in England
by: Rachel Halford, et al.
Published: (2023-12-01)

No Hepatitis Delta Virus Seropositivity among Blood Donors with Overt and Occult Hepatitis B Infection in Dalian, Liaoning Province, China
by: Xuelian Deng, et al.
Published: (2023-07-01)

Epidemiology of occult hepatitis B and C in Africa: A systematic review and meta-analysis
by: Juliette Laure Ndzie Ondigui, et al.
Published: (2022-12-01)

Managing HCV infection in pediatric age group: Suggested recommendations
by: Danish Fazal, et al.
Published: (2010-01-01)

‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
by: Fabrizio Fabrizi, et al.
Published: (2021-11-01)

Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection
by: Yutaka Tsutsumi, et al.
Published: (2023-05-01)

Methodologies for the analysis of HCV-specific CD4+ T cells
by: Megha eLokhande, et al.
Published: (2015-02-01)

HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
by: Mahantesh B Nagamoti, et al.
Published: (2018-04-01)

Occult hepatitis B among Iranian hepatitis C patients
by: Ahmad shavakhi, et al.
Published: (2009-02-01)

The impact of COVID-19 on the cascade of care of HCV in the US and China
by: Yee Hui Yeo, et al.
Published: (2022-05-01)

Successful outcome of transplanting a kidney from a HCV-positive deceased donor into a HCV-negative recipient
by: Zaheer Amin Virani, et al.
Published: (2018-01-01)

HIV, HCV and HBV: A Review of Parallels and Differences
by: Maria C. Leoni, et al.
Published: (2018-09-01)

Prevalence and effect of occult hepatitis C infection in patients with persistent liver enzyme elevation after achieving 24 weeks of sustained virological response
by: Anwar A Mohamed, et al.
Published: (2019-01-01)

Results for anti-HCV and HCV RNA between the years of 2004 and 2005 in Southeast Turkey (Diyarbakır)
by: Ozekinci Tuncer and Atmaca Selahattin
Published: (2007-08-01)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
Published: (2006-04-01)

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
by: Mathias Jachs, et al.
Published: (2023-08-01)

Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome
by: Eirini I. Rigopoulou, et al.
Published: (2014-01-01)

EPIDEMIOLOGICAL CHARACTERISTIC OF VIRAL HEPATITIS B AND C IN THE HEMODIALYSIS UNITS IN SAINT-PETERSBURG IN MODERN TIME. Part 1. Registration of hemo-contact viral hepatitis and serological markers of HBV and HCV infections in patients of hemodialysis unit
by: S. L. Mukomolov, et al.
Published: (2014-06-01)